New drug poised to transform pancreatic cancer care after FDA approval
The FDA has approved a new targeted drug for advanced pancreatic cancer. In a clinical trial, it helped patients live twice as long compared to those treated with standard chemotherapy.
Ähnliche Seiten
A Game-Changing Drug for Pancreatic Cancer Just Got FDA Approval